M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells

M3814, also known as nedisertib, is a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor under phase 2 clinical trials. ABCG2 is a member of the ATP-binding cassette (ABC) transporter family that is closely related to multidrug resistance (MDR) in cancer treatment. In this study, w...

Full description

Bibliographic Details
Main Authors:	Zhuo-Xun Wu, Zheng Peng, Yuqi Yang, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Yi-Ge Fu, Ketankumar Patel, Lili Liu, Lizhu Lin, Chang Zou, Zhe-Sheng Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-05-01
Series:	Frontiers in Oncology
Subjects:	ATP-binding cassette (ABC) transporter M3814 nedisertib ABCG2 multidrug resistance (MDR)
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.00674/full

Similar Items

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance
by: Zhuo-Xun Wu, et al.
Published: (2020-01-01)

Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells
by: Jingqiu Wang, et al.
Published: (2020-02-01)

The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter
by: Silpa Narayanan, et al.
Published: (2021-02-01)

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro
by: Yuqi Yang, et al.
Published: (2020-05-01)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
by: Wei Zhang, et al.
Published: (2018-10-01)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
by: Ning Ji, et al.
Published: (2018-10-01)

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor
by: Zhuo-Xun Wu, et al.
Published: (2021-07-01)

Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport
by: Chung-Pu Wu, et al.
Published: (2023-11-01)

Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo
by: Xiaoran Guo, et al.
Published: (2018-02-01)

VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study
by: Silpa Narayanan, et al.
Published: (2021-09-01)

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
by: Jing-Quan Wang, et al.
Published: (2020-02-01)

The Alternating Access Mechanism in Mammalian Multidrug Resistance Transporters and Their Bacterial Homologs
by: Shadi A Badiee, et al.
Published: (2023-05-01)

Multidrug resistance of Botrytis cinerea associated with its adaptation to plant secondary metabolites
by: Zhaochen Wu, et al.
Published: (2024-02-01)

Medically Important Alterations in Transport Function and Trafficking of ABCG2
by: László Homolya
Published: (2021-03-01)

Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo
by: Li Yang, et al.
Published: (2018-05-01)

A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo
by: Shoji Kokubo, et al.
Published: (2021-11-01)

Transmembrane Polar Relay Drives the Allosteric Regulation for ABCG5/G8 Sterol Transporter
by: Bala M. Xavier, et al.
Published: (2020-11-01)

DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer
by: Manni Wang, et al.
Published: (2021-12-01)

Pharmacogenetic Aspects of the Interaction of AT1 Receptor Antagonists With ATP-Binding Cassette Transporter ABCG2
by: Anne Ripperger, et al.
Published: (2018-05-01)

Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells
by: Yan-Qing Li, et al.
Published: (2022-10-01)

Impact of Q141K on the Transport of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by ABCG2
by: Yutaka Inoue, et al.
Published: (2019-07-01)

Cellular Processing of the ABCG2 Transporter—Potential Effects on Gout and Drug Metabolism
by: Orsolya Mózner, et al.
Published: (2019-10-01)

GmABCG5, an ATP-binding cassette G transporter gene, is involved in the iron deficiency response in soybean
by: Yu Wang, et al.
Published: (2024-01-01)

ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma
by: Haofei Wang, et al.
Published: (2017-03-01)

PCI29732, a Bruton’s Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells
by: Chunlei Ge, et al.
Published: (2018-08-01)

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
by: Gangyang Wang, et al.
Published: (2022-01-01)

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
by: Yuqi Yang, et al.
Published: (2021-02-01)

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
by: Chung-Pu Wu, et al.
Published: (2023-09-01)

ABCG11 modulates cytokinin responses in Arabidopsis thaliana
by: Qianying Yang, et al.
Published: (2022-07-01)

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
by: Yi-Dong Li, et al.
Published: (2020-06-01)

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
by: Yongchao Zhang, et al.
Published: (2020-11-01)

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP
by: Sophie E. B. Ambjørner, et al.
Published: (2020-03-01)

BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
by: Yunali V. Ashar, et al.
Published: (2020-09-01)

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)
by: Juan Pablo Rigalli, et al.
Published: (2024-04-01)

Analysis of Sequence Divergence in Mammalian ABCGs Predicts a Structural Network of Residues That Underlies Functional Divergence
by: James I. Mitchell-White, et al.
Published: (2021-03-01)

MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study
by: Zhuo-Xun Wu, et al.
Published: (2022-05-01)

ATP-BINDING CASSETTE TRANSPORTERS (ABC). NOMENCLATURE, STRUCTURE, MOLECULAR DIVERSITY, FUNCTION, CONTRIBUTION TO THE FUNCTIONING OF THE XENOBIOTICS TRANSFORMATION SYSTEM (А REWIEW)
by: Lev Smirnov
Published: (2020-04-01)

Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas
by: Kyung Woo Kim, et al.
Published: (2021-03-01)

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer
by: Kun Liu, et al.
Published: (2021-05-01)

ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL
by: Ashley M. Vaughan, et al.
Published: (2006-11-01)